Felzartamab for IgA Nephropathy: Final Results of the IGNAZ Study: SA-OR101
Barratt, Jonathan, Floege, Jürgen, Lafayette, Richard A., Schwartz, Brian M., Patel, Uptal D., Manser, Paul, Kivman, Lisa, Haertle, Stefan, Faulhaber, Nicola, Thakur, Anjali G., Barbour, Sean
Published in Journal of the American Society of Nephrology (01.10.2024)
Published in Journal of the American Society of Nephrology (01.10.2024)
Get full text
Journal Article
Felzartamab Durably Reduces Disease-Relevant Biomarkers through Targeting of CD38+ Plasma Cells and Plasmablasts, the Upstream Drivers of IgAN: FR-OR69
Barratt, Jonathan, Shah, Millie, Kivman, Lisa, Kräft, Tabea, Rauser, Julia, Boxhammer, Rainer, Haertle, Stefan, Schwartz, Brian M., Manser, Paul, Chinn, Leslie, Patel, Uptal D., Flesher, Donna, Kiryluk, Krzysztof
Published in Journal of the American Society of Nephrology (01.10.2024)
Published in Journal of the American Society of Nephrology (01.10.2024)
Get full text
Journal Article
425 Felzartamab (anti-CD38) in patients with IgA Nephropathy—interim results from the IGNAZ study
Floege, Jürgen, Lafayette, Richard, Barratt, Jonathan, Schwartz, Brian, Manser, Paul T, Patel, Uptal D, Pineda, Lilia, Faulhaber, Nicola, Boxhammer, Rainer, Haertle, Stefan, Thakur, Anjali, Barbour, Sean
Published in Nephrology, dialysis, transplantation (23.05.2024)
Published in Nephrology, dialysis, transplantation (23.05.2024)
Get full text
Journal Article
Felzartamab Reduces aPLA2R Ab by Selectively Depleting CD38+ Plasma Cells and Plasmablasts, the Main Pathogenic Cellular Drivers of Disease in Primary Membranous Nephropathy (PMN): SA-PO910
Flesher, Donna, Boxhammer, Rainer, Kräft, Tabea, Kivman, Lisa, Haertle, Stefan, Dudani, Jaideep, Gilbert, Houston N., Patel, Uptal D., Rovin, Brad H.
Published in Journal of the American Society of Nephrology (01.11.2023)
Published in Journal of the American Society of Nephrology (01.11.2023)
Get full text
Journal Article
Neutralization of IL-17C Reduces Skin Inflammation in Mouse Models of Psoriasis and Atopic Dermatitis
Vandeghinste, Nick, Klattig, Jürgen, Jagerschmidt, Catherine, Lavazais, Stéphanie, Marsais, Florence, Haas, Jan D., Auberval, Marielle, Lauffer, Felix, Moran, Tara, Ongenaert, Mate, Van Balen, Maarten, Dupont, Sonia, Lepescheux, Liên, Garcia, Teresa, Härtle, Stefan, Eyerich, Kilian, Fallon, Padraic G., Brys, Reginald, Steidl, Stefan
Published in Journal of investigative dermatology (01.07.2018)
Published in Journal of investigative dermatology (01.07.2018)
Get full text
Journal Article
Safety and Efficacy of Felzartamab in Primary Membranous Nephropathy (PMN): Final Analysis of the M-PLACE Study: TH-OR27
Rovin, Brad H., Ronco, Pierre M., Wetzels, Jack F., Adler, Sharon G., Ayoub, Isabelle, Han, Seung Hyeok, Dudani, Jaideep, Gilbert, Houston N., Patel, Uptal D., Jauch-Lembach, Julia, Faulhaber, Nicola, Boxhammer, Rainer, Haertle, Stefan, Sprangers, Ben
Published in Journal of the American Society of Nephrology (01.11.2023)
Published in Journal of the American Society of Nephrology (01.11.2023)
Get full text
Journal Article
Felzartamab in Patients with Anti-Phospholipase A2 Receptor Autoantibody Positive (Anti-PLA2R+) Membranous Nephropathy (MN): Interim Results from the M-PLACE Study: PO1647
Rovin, Brad H., Adler, Sharon G., Hoxha, Elion, Sprangers, Ben, Stahl, Rolf A., Wetzels, Jack F., Schwamb, Bettina, Boxhammer, Rainer, Nguyen, Quynh, Haertle, Stefan, Ronco, Pierre M.
Published in Journal of the American Society of Nephrology (01.10.2021)
Published in Journal of the American Society of Nephrology (01.10.2021)
Get full text
Journal Article
Safety and Efficacy of Felzartamab (MOR202) in Anti-Phospholipase A2 Receptor (PLA2R) Autoantibody-Positive Membranous Nephropathy: The M-PLACE Study: SA-PO679
Rovin, Brad H., Ronco, Pierre M., Wetzels, Jack F., Adler, Sharon G., Ayoub, Isabelle, Zaoui, Philippe, Han, Seung Hyeok, Jauch-Lembach, Julia, Faulhaber, Nicola, Cui, Jie, Haertle, Stefan, Sprangers, Ben
Published in Journal of the American Society of Nephrology (01.11.2022)
Published in Journal of the American Society of Nephrology (01.11.2022)
Get full text
Journal Article
Tissue and time specific expression pattern of interferon regulated genes in the chicken
Röll, Susanne, Härtle, Stefan, Lütteke, Thomas, Kaspers, Bernd, Härtle, Sonja
Published in BMC genomics (28.03.2017)
Published in BMC genomics (28.03.2017)
Get full text
Journal Article
Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial
Mayer, Katharina A, Budde, Klemens, Halloran, Philip F, Doberer, Konstantin, Rostaing, Lionel, Eskandary, Farsad, Christamentl, Anna, Wahrmann, Markus, Regele, Heinz, Schranz, Sabine, Ely, Sarah, Firbas, Christa, Schörgenhofer, Christian, Kainz, Alexander, Loupy, Alexandre, Härtle, Stefan, Boxhammer, Rainer, Jilma, Bernd, Böhmig, Georg A
Published in Current controlled trials in cardiovascular medicine (08.04.2022)
Published in Current controlled trials in cardiovascular medicine (08.04.2022)
Get full text
Journal Article
Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody–Positive Primary Membranous Nephropathy
Rovin, Brad H., Ronco, Pierre M., Wetzels, Jack F.M., Adler, Sharon G., Ayoub, Isabelle, Zaoui, Philippe, Han, Seung Hyeok, Dudani, Jaideep S., Gilbert, Houston N., Patel, Uptal D., Manser, Paul T., Jauch-Lembach, Julia, Faulhaber, Nicola, Boxhammer, Rainer, Härtle, Stefan, Sprangers, Ben
Published in Kidney international reports (01.09.2024)
Published in Kidney international reports (01.09.2024)
Get full text
Journal Article
Molecular basis of in vitro affinity maturation and functional evolution of a neutralizing anti-human GM-CSF antibody
Eylenstein, Roy, Weinfurtner, Daniel, Härtle, Stefan, Strohner, Ralf, Böttcher, Jark, Augustin, Martin, Ostendorp, Ralf, Steidl, Stefan
Published in mAbs (01.01.2016)
Published in mAbs (01.01.2016)
Get full text
Journal Article